Original Articles
- 1 March 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 154 (6), 929-933
- https://doi.org/10.1097/00005392-199503001-00010
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladderEuropean Journal Of Cancer, 1993
- Use of Intravesical Bacillus Calmette-Guérin in the Treatment of Superficial Transitional Cell Carcinoma of the Bladder: An OverviewUrologia Internationalis, 1990
- Role of Fibronectin in Intravesical BCG Therapy for Superficial Bladder CancerJournal of Urology, 1988
- Single Course Versus Maintenance Bacillus Calmette-Guerin Therapy for Superficial Bladder Tumors: A Prospective, Randomized TrialJournal of Urology, 1987
- Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment ResultsJournal of Urology, 1985
- Long-Term Mitomycin C Instillation After Transurethral Resection of Superficial Bladder Carcinoma: Influence on Recurrence, Progression and SurvivalJournal of Urology, 1984
- Bladder Cancer ImmunotherapyJournal of Urology, 1982
- Role of intravesical mitomycin c in management of superficial bladder tumorsUrology, 1980